There’s a “good news, bad news” situation happening now with SoFi Technologies (NASDAQ:SOFI). The good news is that SoFi just acquired a mortgage lender and this will diversify the company’s business model. On the other hand, the Supreme Court’s recent student loan ruling could be problematic for SoFi Technologies. All in all, it makes sense to
0 Comments
Investors may want to keep an eye on the biotech boom and these top biotech stocks to watch. For one, the sector is still one of the safest, most recession-proof investments around. Two, an aging population is demanding better treatment in an effort to live longer lives. Three, there’s the incredible new innovation in gene therapies, immuno-oncology,
0 Comments
Tesla is on deck, along with 4 other must-watch companies. Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
0 Comments
Investing would be a lot easier if you didn’t have to worry about underperforming stocks to get rid of. Wouldn’t it be great if stocks did what you thought they would do when you bought them? But that’s part of the game you play when you invest in the stock market. We can use tools, metrics
0 Comments
After bouncing back strongly at the start of 2023, AMC Entertainment (NYSE:AMC) stock has traded sideways in more recent months. Currently at around $5 per share, AMC stock may look tempting, for risk-hungry investors bullish that the popular “meme stock” will soon resume making big moves. Unfortunately, while shares in the movie theater chain may
0 Comments
When it comes to investing for the long-haul, blue-chip stocks may first come to mind. However, alongside these venerable, steady names, adding a few of the best stocks to buy for long-term growth may be another profitable decision to make. The emphasis here, of course, is on “long-term,” rather than merely “growth.” There are plenty
0 Comments
Fundamentally, the driving catalyst for biotech stocks to buy centers on the possibility of supporting paradigm-shifting medical breakthroughs. For example, a report published by the JAMA Network indicates that experts project the global economic cost of cancers from 2020 to 2050 will be $25.2 trillion (in constant 2017 dollar terms). Therefore, finding a cure would
0 Comments
While the concept of acquiring low-PE ratio blue-chip stocks (that is, industry-leading stalwarts that feature low price-earnings ratios relative to their sectors) appeals on paper, investors need to be cautious. You can’t just buy companies based on any one single metric. In addition, sometimes a very cheap PE can actually signal significant fundamental problems. Instead,
0 Comments
Without question, tech has been the best-performing group so far in 2023. Understandably, that’s got investors looking at the best tech stocks to buy.  At the same time though, that does create a tough situation. On the one hand, investors want to stick with what’s working. The mentality of “The trend is your friend” has
0 Comments
Welcome to another week of Hypergrowth Investing, folks! With earnings season underway, we’re laser-focused on companies’ first-quarter results and what that means for stocks going forward. As we’ve mentioned previously, in the first three months of this year, both the labor market and consumer spending were quite resilient. And those two factors should support strong
0 Comments